Condition
Multiple Myeloma Progression clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Multiple Myeloma Progression clinical trials that are recruiting, at sites in 4 countries (most in United States (2), Australia (1), China (1)). By phase: Phase 1 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 4Countries
Newest Multiple Myeloma Progression clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| KLN-1010 gene therapy for relapsed or refractory multiple myeloma | Phase 1 | Duarte, California and 10 other locations | Recruiting | Jul 20, 2025 |
| Sequential CAR-T therapy targeting BCMA and GPRC5D for relapsed or refractory multiple myeloma | Phase 1/2 | Beijing, Beijing Municipality | Recruiting | Jun 22, 2025 |
| Identifying precancerous multiple myeloma in African American adults | — | Charlotte, North Carolina | Recruiting | Oct 16, 2024 |
| Early palliative care for patients with multiple myeloma and aggressive lymphoma | — | Toronto, Ontario | Recruiting | Jul 3, 2024 |
All recruiting trials (4)
-
KLN-1010 gene therapy for relapsed or refractory multiple myeloma
This Phase 1 trial will try KLN-1010, an in vivo CAR‑T gene therapy, to see if it is safe and can be given at a tolerable dose for people with relapsed or refractory multiple myeloma who have had at least three prior therapies.
-
Sequential CAR-T therapy targeting BCMA and GPRC5D for relapsed or refractory multiple myeloma
This will try sequential CAR-T cell therapy against BCMA and GPRC5D in people with relapsed or refractory multiple myeloma to see if it is safe and helps control the disease.
-
Identifying precancerous multiple myeloma in African American adults
This study is testing a way to find early signs of multiple myeloma in Black and African American adults aged 30 and older to help catch it sooner and improve their health outcomes.
-
Early palliative care for patients with multiple myeloma and aggressive lymphoma
This study is testing if early palliative care can improve the quality of life and comfort for people with multiple myeloma and aggressive lymphoma while they receive their usual cancer treatment.
Related topics
Quick answers
How many Multiple Myeloma Progression clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (2 trials), Australia (1 trial), China (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.